Stocktoria

ACCENDRA HEALTH INC/VA/ ACH

NYSE · stock · Wholesale-Medical, Dental & Hospital Equipment & Supplies · website · IPO 1980-03-17

ACCENDRA HEALTH INC/VA/ statistics & valuation

Market cap$255.8M
P / S0.1×
Net margin-39.8%
FCF margin-10.6%
Return on capital1.8%

Market cap as of 2026-06-29. Multiples are price-derived and refreshed daily; everything else from the latest financial reports.

Profitability & efficiency

Net margin (%)
1.10% 0.80% -4.60% -0.70% 0.40% 2.30% 0.20% -1.60% -13.50% -39.80% 2016201720182019202020212022202320242025
Gross margin (%)
12.20% 12.60% 11.40% 12.30% 15.10% 15.50% 18.30% 83.30% 82.80% 2016201720182019202020212022202320242025
Operating margin (%)
2.10% 1.00% -3.70% 0.80% 2.40% 3.80% 1.40% 5.20% -8.10% 1.00% 2016201720182019202020212022202320242025
Return on equity (%)
11.30% 7.20% -84.30% -13.50% 4.20% 23.60% 2.30% -4.40% -61.90% 2016201720182019202020212022202320242025
Shares outstanding
61.1M 61.5M 61.5M 62.8M 73.5M 75.5M 76.3M 77.4M 77.2M 76.9M 2016201720182019202020212022202320242025
Net debt ($)
$383.9M $812.8M $1.61B $1.49B $942.9M 2016201720182019202020212022202320242025
Share buybacks ($)
2016201720182019202020212022202320242025
Return on assets (%)
4.00% 2.20% -11.60% -1.70% 0.90% 6.30% 0.40% -0.80% -7.80% -44.90% 2016201720182019202020212022202320242025
Free cash flow margin (%)
1.70% 0.20% 0.80% 1.30% 3.40% 0.90% 1.70% 22.30% -0.30% -10.60% 2016201720182019202020212022202320242025
Debt / equity (×)
0.59× 0.90× 3.24× 3.37× 1.44× 2016201720182019202020212022202320242025
EPS ($)
$1.76 -$1.03 $0.47 $2.94 $0.29 -$0.53 -$4.73 -$14.31 2016201720182019202020212022202320242025

Margins and returns computed from annual filings. Falling shares outstanding = buybacks; rising = dilution. Net debt = debt − cash (negative = net cash).

P / E vs its own history

ACCENDRA HEALTH INC/VA/ trades at about 4.2× earnings — below its 10-year norm (10-year range 14.3×–68.1×, median 20.4×).

4.2× 68.1×

Shaded band = 10-year range (14.3×–68.1×); dot = today's 4.2×.

Historical P/E = month-end price near each fiscal year-end ÷ that year's EPS. A read on whether the stock is cheap or dear relative to how it has typically been valued — not a forecast.

Key ratios (by fiscal year)

RatioFY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Gross margin—82.8%83.3%18.3%15.5%15.1%12.3%11.4%12.6%12.2%
Operating margin1.0%-8.1%5.2%1.4%3.8%2.4%0.8%-3.7%1.0%2.1%
Net margin-39.8%-13.5%-1.6%0.2%2.3%0.4%-0.7%-4.6%0.8%1.1%
FCF margin-10.6%-0.3%22.3%1.7%0.9%3.4%1.3%0.8%0.2%1.7%
Return on assets-44.9%-7.8%-0.8%0.4%6.3%0.9%-1.7%-11.6%2.2%4.0%
Return on equity238.8%-61.9%-4.4%2.3%23.6%4.2%-13.5%-84.3%7.2%11.3%
Debt / equity—————1.44×3.37×3.24×0.90×0.59×
Current ratio0.581.091.111.471.731.591.701.721.671.90

Computed from company filings · US · as of 2025-12-31. Facts plus Stocktoria's own computed scores — not investment advice.